Nephrology Provider Perceptions about Recommending Influenza and COVID-19 Vaccines: A Nationwide Survey.

IF 4.3 3区 医学 Q1 UROLOGY & NEPHROLOGY
Guangchen Zou, Lawrence Appel, Deidra C Crews, David Dowdy, Kunihiro Matsushita, Kristin A Riekert, Bernard G Jaar, Junichi Ishigami
{"title":"Nephrology Provider Perceptions about Recommending Influenza and COVID-19 Vaccines: A Nationwide Survey.","authors":"Guangchen Zou, Lawrence Appel, Deidra C Crews, David Dowdy, Kunihiro Matsushita, Kristin A Riekert, Bernard G Jaar, Junichi Ishigami","doi":"10.1159/000544935","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Vaccination rates for influenza and COVID-19 remain low among people with chronic kidney disease (CKD). Nephrology care offers an opportunity to boost vaccination rates. Understanding provider perceptions can be key to developing effective intervention programs.</p><p><strong>Methods: </strong>We conducted a nationwide survey among nephrology care providers. In a questionnaire, we assessed the providers' agreement with potential barriers to recommending influenza and COVID-19 vaccines and perceptions of selected vaccination programs on their acceptability, appropriateness, and feasibility.</p><p><strong>Results: </strong>Between February and June 2023, 312 providers responded to the survey. Most providers agreed that there is sufficient evidence for influenza vaccines (270/311, 86.8%) and that vaccines reduce the risk of serious complications of influenza (277/310, 89.4%). However, 40/312 (12.8%) felt that recommending influenza vaccines is less important than other issues they must address. By profession, more physicians agreed with the evidence (112/123 or 91.1% vs. 39/49 or 79.5% for NPs and 83/101 or 82.2% for RNs, p = 0.007) than nurse practitioners (NPs) or nurses (RNs). The most perceived barrier was lack of self-efficacy: 95/311 (30.5%) felt that many patients will not get vaccinated even if they recommend it. Similar responses were seen for COVID-19 vaccines. Regarding vaccination programs, 209/235 (88.9%), 197/224 (87.9%), and 183/222 (82.4%) providers considered provider reminders acceptable, appropriate, and feasible. 209/239 (87.4%), 198/226 (87.6%), and 187/224 (83.5%) did so for standing orders. Onsite/walk-in vaccinations were viewed as acceptable by 192/242 (79.3%) but less feasible (137/222 or 61.7%). Fewer than 33% of providers perceived patient incentives as acceptable, appropriate, or feasible.</p><p><strong>Conclusions: </strong>Most nephrology care providers believe that influenza and COVID-19 vaccinations offer evidence-based benefits, with slightly higher belief among physicians compared to NPs or RNs. However, important barriers to vaccination remain. Standing orders, provider reminders, and onsite/walk-in vaccination are favorably perceived by providers.</p>","PeriodicalId":7570,"journal":{"name":"American Journal of Nephrology","volume":" ","pages":"1-13"},"PeriodicalIF":4.3000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000544935","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Vaccination rates for influenza and COVID-19 remain low among people with chronic kidney disease (CKD). Nephrology care offers an opportunity to boost vaccination rates. Understanding provider perceptions can be key to developing effective intervention programs.

Methods: We conducted a nationwide survey among nephrology care providers. In a questionnaire, we assessed the providers' agreement with potential barriers to recommending influenza and COVID-19 vaccines and perceptions of selected vaccination programs on their acceptability, appropriateness, and feasibility.

Results: Between February and June 2023, 312 providers responded to the survey. Most providers agreed that there is sufficient evidence for influenza vaccines (270/311, 86.8%) and that vaccines reduce the risk of serious complications of influenza (277/310, 89.4%). However, 40/312 (12.8%) felt that recommending influenza vaccines is less important than other issues they must address. By profession, more physicians agreed with the evidence (112/123 or 91.1% vs. 39/49 or 79.5% for NPs and 83/101 or 82.2% for RNs, p = 0.007) than nurse practitioners (NPs) or nurses (RNs). The most perceived barrier was lack of self-efficacy: 95/311 (30.5%) felt that many patients will not get vaccinated even if they recommend it. Similar responses were seen for COVID-19 vaccines. Regarding vaccination programs, 209/235 (88.9%), 197/224 (87.9%), and 183/222 (82.4%) providers considered provider reminders acceptable, appropriate, and feasible. 209/239 (87.4%), 198/226 (87.6%), and 187/224 (83.5%) did so for standing orders. Onsite/walk-in vaccinations were viewed as acceptable by 192/242 (79.3%) but less feasible (137/222 or 61.7%). Fewer than 33% of providers perceived patient incentives as acceptable, appropriate, or feasible.

Conclusions: Most nephrology care providers believe that influenza and COVID-19 vaccinations offer evidence-based benefits, with slightly higher belief among physicians compared to NPs or RNs. However, important barriers to vaccination remain. Standing orders, provider reminders, and onsite/walk-in vaccination are favorably perceived by providers.

肾脏病提供者对推荐流感和COVID-19疫苗的看法:一项全国性调查。
背景:慢性肾脏疾病(CKD)患者的流感和COVID-19疫苗接种率仍然很低。肾病护理为提高疫苗接种率提供了机会。了解提供者的看法是制定有效干预方案的关键。方法:我们对肾病护理人员进行了全国性调查。在一份问卷中,我们评估了提供者是否同意推荐流感和COVID-19疫苗的潜在障碍,以及对所选疫苗接种计划的可接受性、适当性和可行性的看法。结果:在2023年2月至6月期间,312家供应商回应了调查。大多数提供者同意,有足够的证据支持流感疫苗(270/311,86.8%),疫苗可降低流感严重并发症的风险(277/310,89.4%)。然而,312人中有40人(12.8%)认为推荐流感疫苗不如他们必须解决的其他问题重要。按专业划分,内科医生比执业护士(NPs)或护士(RNs)更认同证据(112/123或91.1%,NPs为39/49或79.5%,注册护士为83/101或82.2%,p = 0.007)。最大的障碍是缺乏自我效能感:95/311(30.5%)认为即使他们建议接种疫苗,许多患者也不会接种。COVID-19疫苗也出现了类似的反应。关于疫苗接种计划,209/235(88.9%)、197/224(87.9%)和183/222(82.4%)的提供者认为提供者提醒是可接受的、适当的和可行的。209/239号(87.4%)、198/226号(87.6%)和187/224号(83.5%)是长期订单。192/242(79.3%)认为现场/预约接种是可接受的,但不太可行(137/222或61.7%)。不到33%的医疗服务提供者认为患者的激励是可接受的、适当的或可行的。结论:大多数肾脏病护理提供者认为流感和COVID-19疫苗接种提供循证益处,与NPs或注册护士相比,医生的信念略高。然而,接种疫苗的重要障碍仍然存在。长期订单,提供者提醒,和现场/上门接种疫苗是良好的感知提供者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American Journal of Nephrology
American Journal of Nephrology 医学-泌尿学与肾脏学
CiteScore
7.50
自引率
2.40%
发文量
74
审稿时长
4-8 weeks
期刊介绍: The ''American Journal of Nephrology'' is a peer-reviewed journal that focuses on timely topics in both basic science and clinical research. Papers are divided into several sections, including:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信